The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) solicits R43/R44 grant applications to catalyze major advances in single-molecule protein sequencing through technology development. The goal of this initiative is to achieve technological advances over the next five years that enable generation of protein sequencing data at sufficient scale, speed, cost and accuracy to use routinely in studies of genome biology and function, and in biomedical and clinical research in general. Exploration of methods other than those currently being commercialized is highly encouraged.
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): October 1, 2021; June 15, 2022; June 15, 2023
PAR-21-247 Expiration Date June 16, 2023
Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.